IP Library Granted Patent US 7,081,133
Granted Patent B2
US 7,081,133 · App. 09/746,712 · Granted Jul 25, 2006

Antibiotic treated implantable medical devices

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,081,133
App. No.
09/746,712
Granted
Jul 25, 2006
Kind
B2
Abstract

Pannus-resisting implantable medical devices comprise one or more antimicrobial reservoirs, each such reservoir incorporating antimicrobial substances in predetermined distributions for timed release in vivo. Predetermined distributions of antimicrobial substances incorporated in antimicrobial reservoirs are achieved through use of fluid solvent carriers, which may comprise supercritical fluid solvents. Precipitation of antimicrobial substances from such solvent carriers in predetermined distributions is accomplished through evaporation and/or application of heating, cooling or decreased ambient pressure to the solvent carriers.

Claims (16)

1. A method of providing resistance to pannus overgrowth to an implantable prosthetic heart valve comprising:

A) providing an implantable heart valve comprising a valve orifice defining a blood flow area, a leaflet coupled to said orifice for movement between an open position and a closed position, and a sewing cuff coupled to said orifice, said sewing cuff comprising a material suitable for retaining an antibiotic;

B) providing an antibiotic solution comprising minocycline and rifampin dissolved in a solvent, wherein said solvent comprises SCO2;

C) contacting said material suitable for retaining an antibiotic and said antibiotic solution to obtain an antimicrobial reservoir;

D) removing the solvent from said antimicrobial reservoir; and

E) implanting said heart valve.

2. The method of claim 1 wherein said solvent comprises a cosolvent selected from the group consisting of C1 to C6 alcohols, C1 to C6 ethers, C1 to C6 aldehydes, pyrrolidinones, dimethyl sulfoxide, dimethyl formamide, acetonitrile, and acetic acid.

3. A method of providing resistance to pannus overgrowth to an implantable prosthetic heart valve comprising:

a) providing a sewing cuff comprising a material suitable for retaining an antibiotic;

b) providing an antibiotic solution comprising minocycline and rifampin dissolved in a solvent, wherein said solvent comprises SCO2;

c) contacting said material suitable for retaining an antibiotic and said antibiotic solution to obtain a sewing cuff comprising an antimicrobial reservoir;

d) removing the solvent from said antimicrobial reservoir;

e) providing an implantable heart valve comprising a valve orifice having an interior surface defining a flow area, an exterior peripheral surface, and a leaflet coupled to said orifice for movement between an open position and a closed position;

f) coupling said sewing cuff to said exterior peripheral surface of said heart valve; and

g) implanting said heart valve.

4. The method of claim 3 wherein said solvent comprises a cosolvent selected from the group consisting of C1 to C6 alcohols, C1 to C6 ethers, C1 to C6 aldehydes, pyrrolidinones, dimethyl sulfoxide, dimethyl formamide, acetonitrile, and acetic acid.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2021
From: LIVANVOA USA, INC.
To: CORCYM S.R.L.
Reel/Frame 056544/0121 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2003
From: CHINN, JOSEPH ANDREW; CASANOVA, R. MICHAEL
To: SULZER CARBOMEDICS INC.
Reel/Frame 014806/0416 →
CHANGE OF NAME Recorded Dec 19, 2003
From: SULZER CARBOMEDICS INC.
To: CARBOMEDICS INC.
Reel/Frame 014806/0985 →